612 related articles for article (PubMed ID: 31888723)
21. Prophylactic treatment of vestibular migraine.
Salmito MC; Duarte JA; Morganti LOG; Brandão PVC; Nakao BH; Villa TR; Ganança FF
Braz J Otorhinolaryngol; 2017; 83(4):404-410. PubMed ID: 27320656
[TBL] [Abstract][Full Text] [Related]
22. [investigation on the triggers and the effect of healthy education on recurrence of vestibular migraine].
Xiao BJ; Bi Y; Zheng TH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):577-580. PubMed ID: 31327189
[No Abstract] [Full Text] [Related]
23. Influence of Role Expectancy on Patient-Reported Outcomes Among Patients With Migraine: A Randomized Clinical Trial.
May A; Carvalho GF; Schwarz A; Basedau H
JAMA Netw Open; 2024 Apr; 7(4):e243223. PubMed ID: 38656579
[TBL] [Abstract][Full Text] [Related]
24. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study.
Diener HC; Hartung E; Chrubasik J; Evers S; Schoenen J; Eikermann A; Latta G; Hauke W;
Cephalalgia; 2001 Mar; 21(2):120-8. PubMed ID: 11422094
[TBL] [Abstract][Full Text] [Related]
26. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Tepper S; Ashina M; Reuter U; Brandes JL; Doležil D; Silberstein S; Winner P; Leonardi D; Mikol D; Lenz R
Lancet Neurol; 2017 Jun; 16(6):425-434. PubMed ID: 28460892
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis.
Streng A; Linde K; Hoppe A; Pfaffenrath V; Hammes M; Wagenpfeil S; Weidenhammer W; Melchart D
Headache; 2006; 46(10):1492-502. PubMed ID: 17115982
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
[TBL] [Abstract][Full Text] [Related]
31. Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Salviz M; Yuce T; Acar H; Karatas A; Acikalin RM
Laryngoscope; 2016 Jan; 126(1):169-74. PubMed ID: 26228645
[TBL] [Abstract][Full Text] [Related]
32. Migraine-related vertigo: diagnostic criteria and prophylactic treatment.
Maione A
Laryngoscope; 2006 Oct; 116(10):1782-6. PubMed ID: 17003732
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
34. Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
Skljarevski V; Oakes TM; Zhang Q; Ferguson MB; Martinez J; Camporeale A; Johnson KW; Shan Q; Carter J; Schacht A; Goadsby PJ; Dodick DW
JAMA Neurol; 2018 Feb; 75(2):187-193. PubMed ID: 29255900
[TBL] [Abstract][Full Text] [Related]
35. Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes Projects.
Teggi R; Colombo B; Albera R; Asprella Libonati G; Balzanelli C; Batuecas Caletrio A; Casani A; Espinoza-Sanchez JM; Gamba P; Lopez-Escamez JA; Lucisano S; Mandalà M; Neri G; Nuti D; Pecci R; Russo A; Martin-Sanz E; Sanz R; Tedeschi G; Torelli P; Vannucchi P; Comi G; Bussi M
Headache; 2018 Apr; 58(4):534-544. PubMed ID: 29205326
[TBL] [Abstract][Full Text] [Related]
36. Napex acupoint thread-embedding combined with metoprolol tartrate tablet for prophylactic treatment of migraine without aura: a randomized controlled trial.
Tao L; Kou R; Liu L; Wang D; Fan G
Zhongguo Zhen Jiu; 2024 Apr; 44(4):389-394. PubMed ID: 38621724
[TBL] [Abstract][Full Text] [Related]
37. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
38. Vestibular migraine: a critical review of treatment trials.
Fotuhi M; Glaun B; Quan SY; Sofare T
J Neurol; 2009 May; 256(5):711-6. PubMed ID: 19252785
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial.
Obermann M; Nägel S; Ose C; Sonuc N; Scherag A; Storch P; Gaul C; Böger A; Kraya T; Jansen JP; Straube A; Freilinger T; Kaube H; Jürgens TP; Diener HC; Katsarava Z; Kleinschnitz C; Holle D
Lancet Neurol; 2021 Jan; 20(1):29-37. PubMed ID: 33245858
[TBL] [Abstract][Full Text] [Related]
40. A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine.
Bayer O; Brémová T; Strupp M; Hüfner K
J Neurol; 2018 Feb; 265(2):291-298. PubMed ID: 29204964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
